Skip to main content

ADIL

Stock
Health Care
Biotechnology

Performance overview

ADIL Price
Price Chart

Forward-looking statistics

Beta
0.92
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

Company info

SectorHealth Care
IndustryBiotechnology
Employees6
Market cap$5.2M

Fundamentals

Enterprise value$21.8K
Revenue$0.0
Revenue per employee
Profit margin0.00%
Debt to equity0.00

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.87
Dividend per share
Revenue per share$0.00
Avg trading volume (30 day)$6M
Avg trading volume (10 day)$16M
Put-call ratio

Macro factor sensitivity

Growth+5.9
Credit-6.3
Liquidity-1.9
Inflation+3.7
Commodities+0.9
Interest Rates-1.8

Valuation

Dividend yield0.00%
PEG Ratio-0.25
Price to sales
P/E Ratio-0.25
Enterprise Value to Revenue
Price to book1.02

Upcoming events

Next earnings dayMay 15, 2025
Next dividend day
Ex. dividend day

News

Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's Why

Adial Pharmaceuticals (ADIL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research (July 10, 2025)
What's Going On With Adial Pharmaceuticals Stock Today?

Shares of small-cap penny stock Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) shares are trading about 20.5% lower at $1.46 per share Wednesday morning. The company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder.

Benzinga (July 20, 2022)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free